The Center for Genomics and Systems Biology (CGSB) at New York University Abu Dhabi (NYUAD) invites applications from individuals to be appointed as a Research Technician. The position will be based ...

To conduct our work, our group develops and applies computational methods and genomics-based technologies. We specialize in utilizing single-cell multi-omics approaches that profile multiple ...

The Genomics Core now has an Illumina NextSeq500 Next Generation Sequencing (NGS) instrument! This will expand our capacity of services already offered for NGS. Feel free to call or email us to find ...

The Norman Lab aims to combine large-scale functional genomics experiments with computational modeling to enable rational engineering of cell state. Our primary model system is the fibroblast, a ...

Given the complexities of these testing approaches, please contact the MGL if you are considering this test or would like to discuss a specific case. The Medical Genomics Laboratory (MGL) is a ...

Genomics is the study of the full genetic complement of an organism (the genome). It employs recombinant DNA, DNA sequencing methods, and bioinformatics to sequence, assemble, and analyse the ...

PLEASANTON, Calif., Oct. 15, 2024 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced today the launch of two new Chromium products intended to ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

DENVER, Nov. 6, 2024 /PRNewswire/ -- CS Genetics, a leader in next-generation single-cell genomics, today announced the ...

The bill prohibits federal agencies from contracting with five companies with clear ties to the Chinese Communist Party: WuXi AppTec, WuXi Biologics, Beijing Genomics Institute, MGI, and its ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...